Transplanted neural stem cell grafts raise brain-derived neurotrophic factor levels and improve behavioral recovery in a mutant hAPP-overexpressing mouse model of AD without affecting Aβ or tau pathology [78]. The gene discussed is MAPT; the disease is Alzheimer disease.